| Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|
Research and development expenses | ||||||||
22,299 | 25,176 | 28,552 | 18,356 | 10,490 | 8,870 | 7,187 | 5,987 | 3,377 |
Less: Participation by the Office of the Chief Scientist | ||||||||
- | - | 196 | 2,912 | 2,237 | 1,573 | 1,756 | 860 | 705 |
U.S. Government grant | ||||||||
- | - | - | - | - | - | - | 0 | 244 |
Participation by third party | ||||||||
- | - | - | - | - | - | - | 75 | 902 |
Research and development expenses | ||||||||
- | - | 28,356 | 15,444 | 8,253 | 7,297 | 5,431 | 5,052 | 1,526 |
Non-recurring research and development expenses resulting from acquisition | ||||||||
- | - | 0 | 8,170 | 0 | 0 | - | - | - |
General and administrative expenses | ||||||||
8,663 | 9,524 | 13,523 | 12,954 | 10,686 | 10,521 | 7,197 | 4,924 | 4,405 |
Excess amount of participation in research and development from third party | ||||||||
- | - | - | - | - | - | - | 0 | 2,577 |
Operating loss | ||||||||
-30,962 | -34,700 | -41,879 | -36,568 | -18,939 | -17,818 | -12,628 | -9,976 | -3,354 |
Financial expenses | ||||||||
1 | 41 | 24 | 1,408 | 68 | 20 | 2,429 | - | - |
Financial income | ||||||||
188 | 27 | 15 | 1 | 586 | 726 | 5 | - | - |
Financial expenses | ||||||||
- | - | - | - | - | - | - | 214 | - |
Financial income | ||||||||
- | - | - | - | - | - | - | 2,097 | - |
Financial expenses | ||||||||
- | - | - | - | - | - | - | - | 1,664 |
Financial income | ||||||||
- | - | - | - | - | - | - | - | 873 |
Loss before taxes on income | ||||||||
-30,775 | -34,714 | -41,888 | -37,975 | -18,421 | -17,112 | -15,052 | -8,093 | -4,145 |
Taxes on income | ||||||||
0 | 0 | 16 | 17 | 12 | 17 | 19 | 3 | 2 |
Net loss | ||||||||
-30,775 | -34,714 | -41,904 | -37,992 | -18,433 | -17,129 | -15,071 | -8,096 | -4,147 |
Basic and diluted loss per share | ||||||||
- | - | - | - | - | - | - | - | -0.95 |
Basic loss per share | ||||||||
-0.50 | -0.83 | -1.19 | -1.42 | 0.96 | -0.97 | -1.37 | -0.96 | - |
Diluted loss per share | ||||||||
-0.50 | -0.83 | -1.19 | -1.45 | 1.00 | -1.06 | -1.37 | -0.96 | - |
Weighted average number of common stock used in computing basic and diluted loss per share | ||||||||
61,381 | 41,675 | 35,161 | 26,783 | 19,246 | 17,629 | 11,023 | 8,447 | - |
Weighted average number of shares of common stock used in computing diluted loss per share | ||||||||
61,381 | 41,675 | 35,161 | 26,846 | 19,294 | 17,683 | 11,023 | 8,447 | - |
Weighted average number of Common stock used in computing basic and diluted loss per share (in shares) | ||||||||
- | - | - | - | - | - | - | - | 4,374 |